Alexander Natz | Secretary General
EUCOPE - European Confederation of Pharmaceutical Entrepreneurs

Alexander Natz, Secretary General, EUCOPE - European Confederation of Pharmaceutical Entrepreneurs

Alexander Natz is the Secretary General of the European Confederation of Pharmaceutical Entrepreneurs (EUCOPE) in Brussels and advises innovative pharmaceutical and biotech companies, including start-ups, in regulatory and pricing & reimbursement matters from the EU law and German law perspective.
From 2008 to 2013, he was Head of the Brussels Office of Bundesverband der Pharmazeutischen Industrie e.V. (BPI). Before, he worked as a lawyer at Sträter Law Firm in Germany with a special focus on managed entry agreements and licensing of pharmaceuticals. Dr. Natz has also worked in the field of competition law with the European Commission and in the pharmaceutical industry.

Appearances:



Day 1 - Tuesday 28 October @ 10:00

Keynote panel: How well has your EUHTA implementation gone?

-Are we stuck in the past? Perspectives from the HTA coordination group: the historical structure of healthcare systems and how this needs to change going forward

-The role of the EUHTA and the need to consider ability and willingness to pay from individual countries

-How will the parallel joint collaboration work between member states?

-How prepared is industry?

Day 1 - Tuesday 28 October @ 14:10

Panel: Platform approach as a new concept – moving away from product authorization?

Invited:

Constanze Blume, Global Regulatory Affairs, BioNTech

Falk Ehmann, Head of Innovation and Development Accelerator, EMA

Day 2 - Wednesday 29 October @ 12:00

Panel: Implications of EU HTA Joint Clinical Assessments to Patient Engagement Practices in Rare Diseases

This panel will explore the practical implications that industry and patient organizations need to consider when engaging given the evolving landscape of HTA in Europe

Day 2 - Wednesday 29 October @ 13:45

Panel: What is the Role of Real-World Evidence for Orphan Products with Single-Arm Trials under the European Joint Clinical Assessment Framework?

last published: 15/Sep/25 16:15 GMT

back to speakers

Get involved at World Orphan Drug Congress Europe 2025

 

 

TO SPONSOR


Steph Scanlon

Steph.Scanlon@terrapinn.com

 

TO SPEAK


Abdu Kauroo
Abdu.Kauroo@terrapinn.com

 

MARKETING & PRESS


Jasper Cameron

Jasper.Cameron@terrapinn.com

 

Stay Up-to-Date

Join our mailing list to receive exclusive content and offers.

By submitting, you agree to receive email communications from Terrapinn, including upcoming promotions and discounted tickets and news.